Encompass Health entered a new credit agreement with Truist Bank and a syndicate of lenders on March 9, 2026. The agreement provides a USD 1.00 billion revolving credit facility, including a USD 260.00 million letter of credit subfacility. It also includes a USD 40.00 million swingline sublimit. Encompass Health drew USD 250.00 million on the revolver to repay and retire amounts outstanding under its prior 2022 credit agreement. The company also reported USD 53.60 million outstanding under the new letter of credit subfacility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000785161-26-000100), on March 10, 2026, and is solely responsible for the information contained therein.